Abstract: SARS-CoV-2 B.1.1.7 (Alpha), a WHO variant of concern first identified in the United Kingdom in late 2020, contains several mutations including
P681H in the
spike S1/S2 cleavage site, which is predicted to increase cleavage by furin, potentially impacting the viral cell entry.